
11 - 50 employees
đ§Ź Biotechnology
đ Pharmaceuticals
âïž Healthcare Insurance
Biotechnology âą Pharmaceuticals âą Healthcare Insurance
Enliven Therapeutics is a company dedicated to developing innovative solutions for cancer treatment. They focus on creating small molecule kinase inhibitors designed to improve efficacy, safety, and patient convenience. With programs targeting BCR-ABL, HER2, and additional pathways, Enliven Therapeutics aims to enhance the precision and selectivity of cancer therapeutics, combat resistance, and address brain metastases. The company prides itself on a team of experienced drug developers and aims to help cancer patients live longer and better lives.
đ April 14
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
đ§Ź Biotechnology
đ Pharmaceuticals
âïž Healthcare Insurance
Biotechnology âą Pharmaceuticals âą Healthcare Insurance
Enliven Therapeutics is a company dedicated to developing innovative solutions for cancer treatment. They focus on creating small molecule kinase inhibitors designed to improve efficacy, safety, and patient convenience. With programs targeting BCR-ABL, HER2, and additional pathways, Enliven Therapeutics aims to enhance the precision and selectivity of cancer therapeutics, combat resistance, and address brain metastases. The company prides itself on a team of experienced drug developers and aims to help cancer patients live longer and better lives.
âą Oversee late-stage drug substance/API development and manufacturing activities to support pivotal studies, regulatory submission, and commercial launch readiness âą Help define and execute phase-appropriate API strategy for late-stage development, ensuring alignment with program milestones and submission goals âą Ensure process design and control strategy are sufficiently established to support pivotal trials, registration, and commercial manufacturing readiness âą Oversee external CDMO/CMO activities for late-stage API manufacturing, process performance, and supply continuity âą Lead technology transfer activities between manufacturing sites to support scale-up, validation, and long-term commercial supply âą Drive process characterization, CPP identification, validation planning, and PPQ readiness/execution for late-stage programs âą Establish, maintain, and refine API control strategy, specifications, and supporting documentation for regulatory submission and commercial readiness âą Oversee drug substance manufacturing campaigns, scheduling, site readiness, and operational execution to ensure timely supply for clinical and registration-enabling activities âą Author, review, and approve technical reports and GMP documentation, including batch records, protocols, specifications, campaign reports, and regulatory CMC submission content âą Partner closely with Quality, Regulatory CMC, Supply Chain, Analytical, Formulation, Legal, and external manufacturers to ensure cGMP compliance, inspection readiness, and successful health authority interactions âą Help represent CMC/DS/API needs to core development team
âą MS or PhD in Organic Chemistry, Chemistry, Chemical Engineering, or a related scientific discipline âą 10+ years of relevant experience in the pharmaceutical or biotechnology industry, including significant hands-on experience in small molecule drug substance/API development and commercialization âą Strong late-stage development experience supporting Phase 3 programs through NDA/BLA or equivalent regulatory submission âą Deep technical expertise in small molecule API process chemistry, development, and scale-up âą Demonstrated experience leading drug substance manufacturing activities in support of late-stage development and commercial readiness âą Experience with process performance qualification, process validation, and commercial launch preparation âą Deep understanding of impurity control strategies, including ICH Q3A/Q3B and ICH M7 âą Strong working knowledge of cGMP requirements and global regulatory expectations, including ICH Q7, Q11, and Q2 âą Experience authoring, reviewing, or contributing to Module 3 and other CMC documentation for regulatory submissions âą Proven readiness to support regulatory inspections, ensure reliable API supply, and deliver successful outcomes across PPQ, submission, and commercial manufacturing.
âą Benefits are included and other incentives such as bonus and equity may be provided.
Apply Nowđ April 14
Technical Director at Hitachi Vantara driving innovation and scalability in core storage ecosystem. Leading strategic initiatives and managing secure infrastructure solutions in critical environments.
đșđž United States â Remote
đ” $250k - $300k / year
â° Full Time
đŽ Lead
đ Director
đŠ H1B Visa Sponsor
đ April 13
Director of Credit Risk Oversight at Best Egg overseeing credit underwriting and portfolio performance. Ensuring alignment with risk appetite and regulations for consumer lending products.
đ April 13
Partnership Director driving growth via strategic partnerships and collaboration across sales and marketing teams. Focused on building mutual growth with channel partners in North America.
đ April 13
đșđž United States â Remote
đ° $59M Private Equity Round - Absorb LMS on 2017-09
â° Full Time
đŽ Lead
đ Director
đ April 13
Executive Director leading communications-support efforts for progressive partners in Tennessee. Driving coalition impact and resources while ensuring effective outreach and advocacy.